Regulatory T cells - An emerging role in transplantation

Yonsei Medical Journal

Volumn 45, Issue 6, 2004, Pages 968-977

  Feng, Gang ^a   Wood, Kathryn ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ALLOGRAFT; ANTIGEN RECOGNITION; AUTOIMMUNITY; BYSTANDER EFFECT; CROSS REACTION; DENDRITIC CELL; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOREGULATION; IMMUNOTHERAPY; IN VITRO STUDY; NONHUMAN; ORGAN TRANSPLANTATION; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 12344336573     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2004.45.6.968     Document Type: Review

References (77)

1. + suppressor T cells: more questions than answers. Nat Rev Immunol 2002;2:389-400.
2. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155:1151-64.
3. Wood K, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003;3:199-210.
4. Gershon RK, Kondo K. Infectious immunological tolerance. Immunology 1971;21:903-14.
5. Mason D, Powrie F. Control of immune pathology by regulatory T cells. Curr Opin Immunol 1998;10:649-55.
6. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Ann Rev Immunol 2004;22:531-62.
7. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 2004;10:801-5.
8. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002; 168:1080-6.
9. Pearson TC, Madsen JC, Larsen CP, Morris PJ, Wood KJ. Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody. Transplantation 1992;54:475-83.
10. Saitovitch D, Bushell A, Mabbs DW, Morris PJ, Wood KJ. Kinetics of induction of transplantation tolerance with a nondepleting anti-CD4 monoclonal antibody and donor-specific transfusion before transplantation. A critical period of time is required for development of immunological unresponsiveness. Transplantation 1996;61:1642-7.
11. Hara M, Kingsley CI, Niimi M, Read S, Turvey SE, Bushell AR, et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001;166:3789-96.
12. + T cell regulation during the induction phase of the response. Eur J Immunol 1995;25:2643-9.
13. - regulatory cells mediate dominant transplantation tolerance. J Immunol 2002;168:5558-65.
14. + T cells. PNAS 2004; 101:10122-6.
15. + regulatory T cells: a potential explanation for the blood-transfusion effect. Transplantation 2003; 76:449-55.
16. Markees TG, Phillips NE, Noelle RJ, Shultz LD, Mordes JP, Greiner DL, et al. Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. Transplantation 1997;64: 329-35.
17. + T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J Immunol 2002;169:5401-4.
18. Isobe M, Yagita H, Okumura K, Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 1992;255:1125-7.
19. Lin H, Bolling SF, Linsley PS, Wei RQ, Gordon D, Thompson CB, et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med 1993;178:1801-6.
20. + T cells in the presence of anti-CD4 monoclonal antibodies: evidence for reduced phosphorylation of Zap-70 and LAT. Scand J Immunol 2003;57:333-41.
21. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389:737-42.
22. + regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001; 2:301-6.
23. + precursors in a thymus-independent process. J Immunol 2004;172:923-8.
24. - precursors. J Immunol 2002;169:4183-9.
25. + regulatory T cells. J Immunol 2004; 172:5986-93.
26. Qin S, Cobbold SP, Pope H, Elliott J, Kioussis D, Davies J, Waldmann H. "Infectious" transplantation tolerance. Science 1993;259:974-7.
27. Onodera K, Lehmann M, Akalin E, Volk HD, Sayegh MH, Kupiec-Weglinski JW. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. J Immunol 1996;157:1944-50.
28. Chen ZK, Cobbold SP, Waldmann H, Metcalfe S. Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation 1996;62:1200-6.
29. + T helper cells. J Exp Med 2002;196:255-60.
30. + regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J Exp Med 2002;196:247-53.
31. Wong W, Morris PJ, Wood KJ. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression. Transplantation 1997; 63:1490-4.
32. - cells to develop suppressive activity: the role of IL-2, TGF-{beta}, and IL-10. J Immunol 2004;172:5213-21.
33. Hamano K, Rawsthorne MA, Bushell AR, Morris PJ, Wood KJ. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients. Transplantation 1996;62:856-60.
34. Karim M, Steger U, Bushell AR, Wood KJ. The role of the graft in establishing tolerance. Front Biosci 2002; 7:e129-54.
35. Fabre JW, Morris PJ. The effect of donor strain blood pretreatment on renal allograft rejection in rats. Transplantation 1972;14:608-17.
36. Cranston D, Wood KJ, Carter N, Morris PJ. Pretreatment with lymphocyte subpopulations and renal allograft survival in the rat. Transplantation 1987;43:809-13.
37. Wong W, Morris PJ, Wood KJ. Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of a fully allogeneic cardiac allograft. Transplantation 1996;62:1462-8.
38. Wood KJ, Evins J, Morris PJ. Suppression of renal allograft rejection in the rat by class I antigens on purified erythrocytes. Transplantation 1985;39:56-62.
39. Hibberd AD, Scott LJ. Allogeneic platelets increase the survival of rat renal allografts. Transplantation 1983;35: 622-4.
40. Madsen J, Superina R, Wood K, Morris P. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 1988;332: 161-4.
41. Miller A, Lider O, Weiner H. Antigen-driven bystander suppression after oral administration of antigens. J Exp Med 1991;174:791-8.
42. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic /suppressive state. Int Immunol 1998;10:1969-80.
43. + immunoregulatory T cells is antigen nonspecific. J Immunol 2000;164:183-90.
44. Brunet JF, Denizot F, Luciani MF, Roux-Dosseto M, Suzan M, Mattei MG, et al. A new member of the immunoglobulin superfamily - CTLA-4. Nature 1987; 328:267-70.
45. Linsley PS, Bradshaw J, Greene J, Peach R, Bennett KL, Mittler RS. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity, 1996;4:535-43.
46. Alegre ML, Frauwirth KA, Thompson CB. T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol 2001; 1:220-8.
47. Tivol E, Borriello F, Schweitzer A, Lynch W, Bluestone J, Sharpe A. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995;3:541-7.
48. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA4. Science 1995;270:985-8.
49. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000; 192:303-10.
50. + regulatory cells that control intestinal inflammation. J Exp Med 2000;192:295-302.
51. + immunoregulatory T cells that control autoimmune diabetes. Immunity 2000;12:431-40.
52. Waldmann H, Cobbold S. How do monoclonal antibodies induce tolerance? A role for infectious tolerance? Annu Rev Immunol 1998;16:619-44.
53. + T cells. J Exp Med 1998;188:1849-57.
54. Fiorentino D, Bond M, Mosmann T. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-95.
55. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
56. Jonuleit H, Schmitt E. The regulatory T cell family: distinct subsets and their interrelations. J Immunol 2003;171:6323-7.
57. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188:287-96.
58. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol 2001;166: 3008-18.
59. + regulatory T cells. Int Immunol 2004;16:249-56.
60. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991;146:3444-51.
61. + T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol. 1993;150:4754-65.
62. + effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. J Exp Med 2003;197:181-93.
63. Kohyama M, Sugahara D, Sugiyama S, Yagita H, Okumura K, Hozumi N. Inducible costimulator-dependent IL-10 production by regulatory T cells specific for setf-antigen. PNAS 2004;101:4192-7.
64. Akbari O, Freeman GJ, Meyer EH, Greenfield EA, Chang TT, Sharpe AH, et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002;8:1024-32.
65. Zelenika D, Adams E, Humm S, Graca L, Thompson S, Cobbold SP, et al. Regulatory T cells overexpress a subset of Th2 gene transcripts. J Immunol 2002;168: 1069-79.
66. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002;195:603-16.
67. + regulatory T cells generated ex vivo with IL-2 and TGF-{beta} suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J Immunol 2004; 172:1531-9.
68. Horwitz DA, Zheng SG, Gray JD, Wang JH, Ohtsuka K, Yamagiwa S. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease. Semin Immunol 2004;16:135-43.
69. Fu F, Li Y, Qian S, Lu L, Chambers F, Starzl TE, et al. Costimulatory molecule- deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996;62:659-65.
70. Lu L, Li W, Fu F, Chambers FG, Qian S, Fung JJ, et al. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor- derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 1997;64:1808-15.
71. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000;192:1213-22.
72. Wakkach A, Cottrez F, Groux H. Differentiation of regulatory T cells 1 is induced by CD2 costimulation. J Immunol 2001;167:3107-13.
73. Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003; 18:605-17.
74. + antigen-specific regulatory T cells. PNAS 2004;101 Suppl 2:14622-6.
75. Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, Ye J, et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004; 199:1455-65.
76. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 2004;199:1467-77.
77. high regulatory T cells. Blood 2004; 104:895-903.